You are here

Umoja Biopharma

Top ten biopharma R&D deals of 2024

Nature

Wed, 06/5/24 - 11:24 am

Argo Biopharmaceutical

MOMA Therapeutics

Boehringer Ingelheim

Suzhou Ribo Life Science

Isomorphic Labs

Gilead Sciences

Umoja Biopharma

Caris Life Sciences

Voyager Therapeutics

AbbVie is big pharma’s first mover in ‘in situ’ cell therapy

Pharmaphorum

Fri, 01/5/24 - 09:48 am

Umoja Biopharma

in situ cell therapy

Venture investors still love drug developers

EP Vantage

Tue, 07/6/21 - 10:32 am

venture capital

Adagio Therapeutics

Umoja Biopharma

Nikang Therapeutics

Apollo Therapeutics